So the label on the three approved drugs is all very similar. The Teva version the only one that does not have an autoinjector.
AMGN the only drug with a non-injection site AE on it's label - constipation at 3% with their higher dose, but as I've mentioned previously seems to be more reported much more often than that. (It's a plausible side effect as CGRP does have a known impact on gut motility - seems to be a defensive mechanism to speed up motility after ingestion of something noxious).
Lilly being very aggressive here with 12 months free. They (unlike AMGN) got Massachusetts right and it's free here too unless the current law is changed in 9 months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.